307 related articles for article (PubMed ID: 26661174)
1. A novel mechanism of neuroprotection: Blood glutamate grabber.
Castillo J; Loza MI; Mirelman D; Brea J; Blanco M; Sobrino T; Campos F
J Cereb Blood Flow Metab; 2016 Feb; 36(2):292-301. PubMed ID: 26661174
[TBL] [Abstract][Full Text] [Related]
2. Targets of cytoprotection in acute ischemic stroke: present and future.
Lizasoain I; Cárdenas A; Hurtado O; Romera C; Mallolas J; Lorenzo P; Castillo J; Moro MA
Cerebrovasc Dis; 2006; 21 Suppl 2():1-8. PubMed ID: 16651809
[TBL] [Abstract][Full Text] [Related]
3. Oxaloacetate: a novel neuroprotective for acute ischemic stroke.
Campos F; Sobrino T; Ramos-Cabrer P; Castillo J
Int J Biochem Cell Biol; 2012 Feb; 44(2):262-5. PubMed ID: 22085530
[TBL] [Abstract][Full Text] [Related]
4. Ischemic stroke: "acidotoxicity" is a perpetrator.
Huang Y; McNamara JO
Cell; 2004 Sep; 118(6):665-6. PubMed ID: 15369664
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
[TBL] [Abstract][Full Text] [Related]
6. Reviving neuroprotection using a new approach: targeting postsynaptic density-95 to arrest glutamate excitotoxicity.
Savitz SI; Schäbitz WR
Stroke; 2012 Dec; 43(12):3411-2. PubMed ID: 23086671
[No Abstract] [Full Text] [Related]
7. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels.
Xiong ZG; Zhu XM; Chu XP; Minami M; Hey J; Wei WL; MacDonald JF; Wemmie JA; Price MP; Welsh MJ; Simon RP
Cell; 2004 Sep; 118(6):687-98. PubMed ID: 15369669
[TBL] [Abstract][Full Text] [Related]
8. Differential pattern of neuroprotection in lumbar, cervical and thoracic spinal cord segments in an organotypic rat model of glutamate-induced excitotoxicity.
Gerardo-Nava J; Mayorenko II; Grehl T; Steinbusch HW; Weis J; Brook GA
J Chem Neuroanat; 2013 Nov; 53():11-7. PubMed ID: 24126226
[TBL] [Abstract][Full Text] [Related]
9. Clinical validation of blood/brain glutamate grabbing in acute ischemic stroke.
da Silva-Candal A; Pérez-Díaz A; Santamaría M; Correa-Paz C; Rodríguez-Yáñez M; Ardá A; Pérez-Mato M; Iglesias-Rey R; Brea J; Azuaje J; Sotelo E; Sobrino T; Loza MI; Castillo J; Campos F
Ann Neurol; 2018 Aug; 84(2):260-273. PubMed ID: 30014516
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury.
Slusher BS; Vornov JJ; Thomas AG; Hurn PD; Harukuni I; Bhardwaj A; Traystman RJ; Robinson MB; Britton P; Lu XC; Tortella FC; Wozniak KM; Yudkoff M; Potter BM; Jackson PF
Nat Med; 1999 Dec; 5(12):1396-402. PubMed ID: 10581082
[TBL] [Abstract][Full Text] [Related]
11. Gene expression in cerebral ischemia: a new approach for neuroprotection.
Millán M; Arenillas J
Cerebrovasc Dis; 2006; 21 Suppl 2():30-7. PubMed ID: 16651812
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective agents for the treatment of acute ischemic stroke.
Ovbiagele B; Kidwell CS; Starkman S; Saver JL
Curr Neurol Neurosci Rep; 2003 Jan; 3(1):9-20. PubMed ID: 12507405
[TBL] [Abstract][Full Text] [Related]
13. GLT-1 Upregulation as a Potential Therapeutic Target for Ischemic Brain Injury.
Hu YY; Li L; Xian XH; Zhang M; Sun XC; Li SQ; Cui X; Qi J; Li WB
Curr Pharm Des; 2017; 23(33):5045-5055. PubMed ID: 28641538
[TBL] [Abstract][Full Text] [Related]
14. Excitatory Synaptic Transmission in Ischemic Stroke: A New Outlet for Classical Neuroprotective Strategies.
Wang F; Xie X; Xing X; Sun X
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012647
[TBL] [Abstract][Full Text] [Related]
15. Brain to blood efflux as a mechanism underlying the neuroprotection mediated by rapid remote preconditioning in brain ischemia.
Jachova J; Gottlieb M; Nemethova M; Bona M; Bonova P
Mol Biol Rep; 2020 Jul; 47(7):5385-5395. PubMed ID: 32627140
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacology of neuroprotection in acute ischemic stroke].
Fernández-Gómez FJ; Hernández F; Argandoña L; Galindo MF; Segura T; Jordán J
Rev Neurol; 2008 Sep 1-15; 47(5):253-60. PubMed ID: 18780272
[TBL] [Abstract][Full Text] [Related]
17. alpha-Amino-3-hydroxy-5-methyl-4-isoxazole propionate attenuates glutamate-induced caspase-3 cleavage via regulation of glycogen synthase kinase 3beta.
Nishimoto T; Kihara T; Akaike A; Niidome T; Sugimoto H
J Neurosci Res; 2008 Apr; 86(5):1096-105. PubMed ID: 18041091
[TBL] [Abstract][Full Text] [Related]
18. Deterioration in acute ischemic stroke as the target for neuroprotection.
Serena J; Rodríguez-Yáñez M; Castellanos M
Cerebrovasc Dis; 2006; 21 Suppl 2():80-8. PubMed ID: 16651818
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol.
Culmsee C; Junker V; Kremers W; Thal S; Plesnila N; Krieglstein J
Stroke; 2004 May; 35(5):1197-202. PubMed ID: 15060319
[TBL] [Abstract][Full Text] [Related]
20. Melatonin improves neuroplasticity by upregulating the growth-associated protein-43 (GAP-43) and NMDAR postsynaptic density-95 (PSD-95) proteins in cultured neurons exposed to glutamate excitotoxicity and in rats subjected to transient focal cerebral ischemia even during a long-term recovery period.
Juan WS; Huang SY; Chang CC; Hung YC; Lin YW; Chen TY; Lee AH; Lee AC; Wu TS; Lee EJ
J Pineal Res; 2014 Mar; 56(2):213-23. PubMed ID: 24350898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
